Food Science and Technology Department

 

Authors

Wenjie Ma, Massachusetts General Hospital and Harvard Medical School
Long H. Nguyen, Massachusetts General Hospital and Harvard Medical School; Harvard T.H. Chan School of Public Health
Mingyang Song, Massachusetts General Hospital and Harvard Medical School; Harvard T.H. Chan School of Public Health
Dong D. Wang, Harvard T.H. Chan School of Public Health
Eric A. Franzosa, Harvard T.H. Chan School of Public Health
Yin Cao, Washington University School of Medicine
Amit Joshi, Massachusetts General Hospital and Harvard Medical School
David A. Drew, Massachusetts General Hospital and Harvard Medical School
Raaj Mehta, Massachusetts General Hospital and Harvard Medical School
Kerry L. Ivey, Harvard T.H. Chan School of Public Health; South Australian Health and Medical Research Institute; Flinders University
Lisa L. Strate, University of Washington School of Medicine
Edward L. Giovannucci, Brigham and Women’s Hospital and Harvard Medical School
Jacques Izard, University of Nebraska–LincolnFollow
Wendy Garrett, Harvard T.H. Chan School of Public Health; Harvard Medical School
Eric B. Rimm, Harvard T.H. Chan School of Public Health; Brigham and Women’s Hospital and Harvard Medical School
Curtis Huttenhower, Harvard T.H. Chan School of Public Health; 18Broad Institute of MIT and Harvard
Andrew T. Chan, Massachusetts General Hospital and Harvard Medical School; Brigham and Women’s Hospital and Harvard Medical School; Harvard T.H. Chan School of Public Health; Broad Institute of MIT and HarvardFollow

Date of this Version

2021

Citation

Ma et al. Genome Medicine (2021) 13:102 https://doi.org/10.1186/s13073-021-00921-y

Comments

© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Abstract

Background: A higher intake of dietary fiber is associated with a decreased risk of chronic inflammatory diseases such as cardiovascular disease and inflammatory bowel disease. This may function in part due to abrogation of chronic systemic inflammation induced by factors such as dysbiotic gut communities. Data regarding the detailed influences of long-term and recent intake of differing dietary fiber sources on the human gut microbiome are lacking. Methods: In a cohort of 307 generally healthy men, we examined gut microbiomes, profiled by shotgun metagenomic and metatranscriptomic sequencing, and long-term and recent dietary fiber intake in relation to plasma levels of C-reactive protein (CRP), an established biomarker for chronic inflammation. Data were analyzed using multivariate linear mixed models. Results: We found that inflammation-associated gut microbial configurations corresponded with higher CRP levels. A greater intake of dietary fiber was associated with shifts in gut microbiome composition, particularly Clostridiales, and their potential for carbohydrate utilization via polysaccharide degradation. This was particularly true for fruit fiber sources (i.e., pectin). Most striking, fiber intake was associated with significantly greater CRP reduction in individuals without substantial Prevotella copri carriage in the gut, whereas those with P. copri carriage maintained stable CRP levels regardless of fiber intake. Conclusions: Our findings offer human evidence supporting a fiber-gut microbiota interaction, as well as a potential specific mechanism by which gut-mediated systemic inflammation may be mitigated.

Included in

Food Science Commons

Share

COinS